Sophia Genetics

Five UK healthcare institutions will use Sophia's Data Driven Medicine Platform, which employs machine learning and algorithms to analyze patients' genomic samples.

The hospitals will use Sophia's Data Driven Medicine Platform to run and validate an NGS-based gene panel that detects mutations for breast and ovarian cancers.

Sophia has developed an algorithm for detecting CNVs from NGS data, and the CE-IVD mark is the second for the company this year.

Sophia Genetics has received ISO 27001 certification for its internally developed information security management system.

NEW YORK (GenomeWeb) – Sophia Genetics, a clinical genomic data analysis services provider, this week launched a new CE-IVD-marked software pipeline that lets clinical researchers identify and characterize genetic variants associated with cystic fibrosis using data from a single next-generation s

Pages

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.